Huawei Watch GT 6 Update Adds Heart Disease Risk Assessment and Voice Messaging

Huawei has begun rolling out HarmonyOS version 6.0.0.188 for its Watch GT 6 and Watch GT 6 Pro smartwatches, introducing several new features focused on health monitoring and messaging capabilities. The update follows the previous version 6.0.0.173 release from late 2025 and is currently being deployed to users in China and other regions.

The HarmonyOS version 6.0.0.188 release notes

Both smartwatch models receive similar core improvements in this update. Users can now set up silent notifications and smart reminders, giving them more granular control over how they receive alerts. Android device owners gain the ability to remotely control their smartphone's camera directly from the watch, a convenient feature for group photos or selfies. The update also includes optimizations for Alipay integration, improving the mobile payment experience for users in supported regions.

A notable addition for Chinese users is the upgraded WeChat app (version 1.1.0) that adds voice-to-text messaging support. This feature allows wearers to dictate messages that are automatically converted to text, making it easier to respond to messages while on the move or when hands-free operation is preferred.

The Huawei Watch GT 6 Pro coronary heart disease risk assessment feature

The Huawei Watch GT 6 Pro receives an exclusive feature that sets it apart from the standard GT 6 model. Huawei is inviting Pro users to participate in a research program focused on coronary heart disease risk assessment. The watch collects data over several days, analyzing various health metrics to determine the wearer's current risk level for heart disease. This appears to be a China-exclusive feature at launch, though it's unclear if Huawei plans to expand it to other markets.

The coronary heart disease risk assessment represents Huawei's continued push into preventive healthcare through wearable technology. By leveraging the watch's continuous heart rate monitoring, sleep tracking, and other biometric sensors, the feature aims to provide early warnings about potential cardiovascular issues. This type of proactive health monitoring aligns with broader industry trends toward using consumer wearables for medical insights.

For those interested in purchasing either model, the Huawei Watch GT 6 is currently available for €232 at Amazon DE. The update rollout timeline remains unclear, with Huawei typically deploying firmware updates in phases across different regions and carrier networks.

This update demonstrates Huawei's strategy of differentiating its smartwatch lineup through region-specific features and health-focused innovations. While the core functionality remains consistent across both models, the coronary heart disease risk assessment gives the Pro version additional appeal for health-conscious consumers, particularly in the Chinese market where such features may face fewer regulatory hurdles than in Western markets.

As wearable technology continues to evolve, features like disease risk assessment could become standard offerings, though they'll likely require careful navigation of medical device regulations and privacy concerns in different jurisdictions.